Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelics R&D
Recent news which mentions Psychedelics R&D
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
Tags
Management
Annual Shareholder Meeting
Psychedelic/Assisted Therapies
From
Benzinga
Mydecine Innovations Group Reports Q2 Financial Results And Management Updates
August 16, 2022
Tickers
MYCOF
Tags
Psychedelics R&D
Psychedelics
Benzinga
From
Benzinga
Report: Psychedelic Therapeutics Global Market Could Be Worth $8.31B By 2028
July 18, 2022
Tags
General
Benzinga
Psychedelics R&D
From
Benzinga
Gilgamesh Advances Pipeline Of Novel Psychoactive Drugs Aimed At Revolutionizing Psychiatric Disorders Treatment
July 18, 2022
Tags
Psychedelics
Psychedelics R&D
Gilgamesh Pharmaceuticals
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.